NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/21/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization563.49 mln
Float16.68 mln
Earnings Date08/13/2026
1-Year Forecast
26.69
Transformational upside
Relative Strength
14
/ 100
Significantly lagging
Debt / Equity
0.01
Debt-free
ROE
-76.42
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
MapLight Therapeutics is a clinical-stage company based in Redwood City, California, focused on developing treatments for serious brain and nervous system conditions such as schizophrenia, Parkinson's disease, autism spectrum disorder, and Alzheimer's disease. The company has built a pipeline of several drug candidates, each targeting specific neurological pathways linked to these conditions. Founded in 2018 and formerly known as Alvarado Therapeutics, MapLight combines drug development with its own research platform designed to identify the brain circuits that drive disease.
